Money and Me: Does Your Retirement Strategy Need an Update?
As Asia ages at record speed, the old “save then spend” playbook is evolving. Michelle Martin speaks with Andy Budden of Capital Group on why a 100-year life demands a complete rethink of investing. F...
25 Mar 20min
Market View: AI Reckoning, Oil Surge & Governance Shock
A $375M verdict, oil profits on steroids, and AI winners splitting from losers - markets are sending sharp signals. Asia-Pacific markets take their cue from Wall Street’s wobble as geopolitics and val...
25 Mar 22min
Influence: Meet The Straits Times Singaporean of the Year, Dr Chen Shiling
Michelle Martin speaks with Dr Chen Shiling, Founder of the Happee Hearts Movement and Straits Times Singaporean of the Year 2025, in this deeply moving conversation on purpose and impact. She could h...
24 Mar 26min
Money and Me: REIT Fatigue & Pharma Shock - What’s Spooking Investors?
From weak demand for REIT fundraising to a sharp selloff in one of Europe’s biggest companies, markets are sending mixed signals, hosted by Michelle Martin with Willie Keng, Founder, Dividend Titan. (...
24 Mar 24min
Market View: Founder Power Boosted, Where is the Oil Whiplash Hurting & Which Market Signals Signal Caution?
A single post moves markets, oil swings wildly, and one founder widens his grip - are investors missing the bigger risks? Markets whipsawed overnight as geopolitics, governance and energy shocks colli...
24 Mar 23min
Influence: The real estate mogul who once asked "Simi si TOP?"
Michelle Martin speaks with Eugene Lim, Founder and CEO of “The Assembly Place,” on the lessons from his new book "The Placemaker" which is about this Singapore entrepreneur how used streetsmarts to d...
23 Mar 24min
Money and Me: Behind Homegrown Gaming Hit - Havendock
What if one person, one idea, and one restless night could build a global gaming success? Michelle Martin sits down with 33-year-old Yeo Ying Zhi, founder of YYZ Studio, to explore how indie developer...
23 Mar 24min
Market View: How is Ozempic changing FnB? The Small Cap Selloff & Big Tech’s AI Device Race
What if the biggest threat to food companies… isn’t inflation but your shrinking appetite? GLP-1 drugs like Ozempic are reshaping consumer behavior, forcing food giants to rethink portions, pricing, ...
23 Mar 23min
